New Key Statistics Module, Z-Score and F-Score
AMEX:AGE Key Ratios
| Market Cap $ M | 27.76 |
| Enterprise Value $ M | 31.78 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 2.19 |
| Price/Sales | 84.73 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -13.75 |
| Beneish M-Score | 1.3 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -109.00 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -3.21 |
| EV-to-EBITDA | -3.25 |
| PEG | -- |
| Shares Outstanding M | 2.50 |
| Net Margin (%) | -10,424.65 |
| Operating Margin % | -7,014.09 |
| Pre-tax Margin (%) | -10,430.28 |
| Quick Ratio | 0.13 |
| Current Ratio | 0.13 |
| ROA % (ttm) | -141.73 |
| ROE % (ttm) | -- |
| ROIC % (ttm) | -47.72 |
| Dividend Yield % | -- |
| Altman Z-Score | -16.05 |
AGE Number of Guru Trades
AGE Volume of Guru Trades
Gurus Latest Trades with AMEX:AGE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
AMEX:AGE is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
AgeX Therapeutics Inc Insider Transactions
No Available Data
News about AMEX:AGE
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers